Study of Forceps Cannulation During ERCP

NACompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

May 12, 2022

Primary Completion Date

October 15, 2024

Study Completion Date

October 21, 2024

Conditions
Post-ERCP Acute Pancreatitis
Interventions
DEVICE

Forceps

The forceps clears the redundant tissue to enable access to the papilla, as well as stabilizes the ampullary position to permit an easier cannulation. The forceps is an FDA approved instrument and does not put the patient at any higher risk for any adverse event. Please note that for the explicit purpose of the study the forceps will be used to grab tissue and not take biopsies. The forceps may still be used to take biopsies if the physician believes it is indicated.

Trial Locations (1)

03756

Dartmouth Health, Lebanon

All Listed Sponsors
lead

Dartmouth-Hitchcock Medical Center

OTHER